Single-agent gemcitabine in patients with resistant small-cell lung cancer

Cancer: Principles and Practice of Oncology

1997 • 1,408 citations

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 • 1,295 citations

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

1997 • 474 citations

Confidence Intervals for Reporting Results of Clinical Trials

1986 • 425 citations

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

1994 • 376 citations

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.

1994 • 364 citations

Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

1999 • 351 citations

Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study

1996 • 246 citations

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

1998 • 176 citations

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)

1994 • 144 citations

Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.

1996 • 132 citations

Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule

1999 • 114 citations

Gemcitabine safety overview.

1996 • 105 citations

Second-line chemotherapy and its evaluation in small cell lung cancer

1999 • 69 citations

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

1992 • 67 citations

Overview of chemotherapy for small cell lung cancer.

1997 • 61 citations

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer

1993 • 58 citations

Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.

1997 • 22 citations